Skip to main content

Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin

The Original Article was published on 11 August 2016

Erratum description

In the original publication of this article [1], one of the co-authors’ names contained a spelling error. ‘Fatiha Meratbene’ should therefore have been listed as ‘Fatiha Merabtene’. The original publication has now been modified as well to reflect these changes.

References

  1. 1.

    Buta C, et al. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res. 2016;35:126. doi:10.1186/s13046-016-0402-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Christèle Desbois-Mouthon.

Additional information

The online version of the original article can be found under doi:10.1186/s13046-016-0402-3.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Buta, C., Benabou, E., Lequoy, M. et al. Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res 35, 154 (2016). https://doi.org/10.1186/s13046-016-0438-4

Download citation